Ruiz M, Braunstein Z, McLaughlin E, Mishra A, Porcu P, Brammer JE. Short-course subcutaneous alemtuzumab induces clinical responses in relapsed T-cell large granular leukemia. haematol [Internet]. 2020Sep.10 [cited 2024Dec.26];. Available from: https://haematologica.org/article/view/11823